Your browser doesn't support javascript.
loading
Identification of nine new susceptibility loci for endometrial cancer.
O'Mara, Tracy A; Glubb, Dylan M; Amant, Frederic; Annibali, Daniela; Ashton, Katie; Attia, John; Auer, Paul L; Beckmann, Matthias W; Black, Amanda; Bolla, Manjeet K; Brauch, Hiltrud; Brenner, Hermann; Brinton, Louise; Buchanan, Daniel D; Burwinkel, Barbara; Chang-Claude, Jenny; Chanock, Stephen J; Chen, Chu; Chen, Maxine M; Cheng, Timothy H T; Clarke, Christine L; Clendenning, Mark; Cook, Linda S; Couch, Fergus J; Cox, Angela; Crous-Bous, Marta; Czene, Kamila; Day, Felix; Dennis, Joe; Depreeuw, Jeroen; Doherty, Jennifer Anne; Dörk, Thilo; Dowdy, Sean C; Dürst, Matthias; Ekici, Arif B; Fasching, Peter A; Fridley, Brooke L; Friedenreich, Christine M; Fritschi, Lin; Fung, Jenny; García-Closas, Montserrat; Gaudet, Mia M; Giles, Graham G; Goode, Ellen L; Gorman, Maggie; Haiman, Christopher A; Hall, Per; Hankison, Susan E; Healey, Catherine S; Hein, Alexander.
Afiliação
  • O'Mara TA; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, 4006, QLD, Australia. Tracy.OMara@qimrberghofer.edu.au.
  • Glubb DM; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, 4006, QLD, Australia.
  • Amant F; Department of Obstetrics and Gynecology, University Hospitals KU Leuven, University of Leuven, Division of Gynecologic Oncology, Leuven, 3000, Belgium.
  • Annibali D; Department of Obstetrics and Gynecology, University Hospitals KU Leuven, University of Leuven, Division of Gynecologic Oncology, Leuven, 3000, Belgium.
  • Ashton K; John Hunter Hospital, Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia.
  • Attia J; University of Newcastle, Centre for Information Based Medicine, Callaghan, 2308, NSW, Australia.
  • Auer PL; University of Newcastle, Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, Callaghan, 2308, NSW, Australia.
  • Beckmann MW; John Hunter Hospital, Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia.
  • Black A; University of Newcastle, Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, Callaghan, 2308, NSW, Australia.
  • Bolla MK; Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, 98109, WA, USA.
  • Brauch H; University of Wisconsin-Milwaukee, Zilber School of Public Health, Milwaukee, 53205, WI, USA.
  • Brenner H; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center ER-EMN, Erlangen, 91054, Germany.
  • Brinton L; National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, 20892, MD, USA.
  • Buchanan DD; Department of Public Health and Primary Care, University of Cambridge, Centre for Cancer Genetic Epidemiology, Cambridge, CB1 8RN, UK.
  • Burwinkel B; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, 70376, Germany.
  • Chang-Claude J; University of Tübingen, Tübingen, 72074, Germany.
  • Chanock SJ; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, 69120, Germany.
  • Chen C; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, 69120, Germany.
  • Chen MM; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
  • Cheng THT; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, 69120, Germany.
  • Clarke CL; National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, 20892, MD, USA.
  • Clendenning M; Department of Clinical Pathology, The University of Melbourne, Melbourne, 3010, VIC, Australia.
  • Cook LS; The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, 3010, VIC, Australia.
  • Couch FJ; Genetic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, 3010, VIC, Australia.
  • Cox A; Victorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Parkville, 3010, VIC, Australia.
  • Crous-Bous M; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, 69120, Germany.
  • Czene K; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
  • Day F; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
  • Dennis J; University Medical Center Hamburg-Eppendorf, Cancer Epidemiology, University Cancer Center Hamburg (UCCH), Hamburg, 20246, Germany.
  • Depreeuw J; National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, 20892, MD, USA.
  • Doherty JA; Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, 98109, WA, USA.
  • Dörk T; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, 02115, MA, USA.
  • Dowdy SC; University of Oxford, Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, Oxford, OX3 7BN, UK.
  • Dürst M; University of Sydney, Westmead Institute for Medical Research, Sydney, 2145, NSW, Australia.
  • Ekici AB; Department of Clinical Pathology, The University of Melbourne, Melbourne, 3010, VIC, Australia.
  • Fasching PA; Victorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Parkville, 3010, VIC, Australia.
  • Fridley BL; University of New Mexico, University of New Mexico Health Sciences Center, Albuquerque, 87131, NM, USA.
  • Friedenreich CM; Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, T2N 4N2, AB, Canada.
  • Fritschi L; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, 55905, MN, USA.
  • Fung J; Department of Oncology and Metabolism, University of Sheffield, Sheffield Institute for Nucleic Acids (SInFoNiA), Sheffield, S10 2TN, UK.
  • García-Closas M; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, 02115, MA, USA.
  • Gaudet MM; Department of Medicine, Harvard Medical School, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, 02115, MA, USA.
  • Giles GG; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, 171 65, Sweden.
  • Goode EL; University of Cambridge, MRC Epidemiology Unit, School of Clinical Medicine, Cambridge, CB2 0QQ, UK.
  • Gorman M; Department of Public Health and Primary Care, University of Cambridge, Centre for Cancer Genetic Epidemiology, Cambridge, CB1 8RN, UK.
  • Haiman CA; Department of Obstetrics and Gynecology, University Hospitals KU Leuven, University of Leuven, Division of Gynecologic Oncology, Leuven, 3000, Belgium.
  • Hall P; VIB, Vesalius Research Center, Leuven, 3000, Belgium.
  • Hankison SE; Department of Human Genetics, University of Leuven, Laboratory for Translational Genetics, Leuven, 3000, Belgium.
  • Healey CS; Cancer Research Huntsman Cancer Institute Department of Population Health Sciences, University of Utah, Salt Lake City, 84112, UT, USA.
  • Hein A; Gynaecology Research Unit, Hannover Medical School, Hannover, 30625, Germany.
Nat Commun ; 9(1): 3166, 2018 08 09.
Article em En | MEDLINE | ID: mdl-30093612
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasias do Endométrio / Predisposição Genética para Doença Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasias do Endométrio / Predisposição Genética para Doença Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália